-
Study aim
-
The study aims to clinically and biochemically assess the effects of Zingiber officinale and Brassica oleracea (cabbage) in patients with knee Osteoarthritis.
-
Design
-
A pragmatic, community-based study. A single-blinded, randomized controlled trial with a parallel group design of 375 patients, will enroll between January 2025 to June 2025
-
Settings and conduct
-
The study will be conducted at Muhammad Physiotherapy and Rehabilitation Center, Multan, Pakistan. After approval obtained from the Iranian Registry of Clinical Trial and institutional ethical committee
-
Participants/Inclusion and exclusion criteria
-
According to the Kellgren and Lawrence system of grading, patients with grade 1-2 knee osteoarthritis, age 40-70 years of either gender (male and female) will be included in this experiment. Patients with neural defects, total knee replacement, RA, injected with steroidal injections in the past 2 years, Tumors in the area of treatment, patients who are not cooperative during the study, and fractures or any other orthopedic condition in the treatment limb will be excluded from this experiment.
-
Intervention groups
-
The patients will be engaged after signing the written consent form. The lottery method will be used for grouping, 375 patients into 3 parallel groups (n=125). Group 1 will be treated with a test herbal gel 5% w/w with phonophoresis with therapeutic ultrasound (frequency of 0.8MH, and an intensity of about 1.5 W/cm2, and with the continuous mode). Group 2 will be treated with the standard drug piroxicam 0.5% w/w with phonophoresis. Group 3 will be treated with therapeutic ultrasound using aqueous gel as coupling media as a placebo or control group. The proprioceptive neuromuscular facilitation (PNF) stretching and muscle energy technique (MET) exercises will be used in 3 groups.
-
Main outcome variables
-
Pain, stiffness, activities of daily living, and inflammation